Trulieve Cannabis Board Approves $50M Buyback Program

Dow Jones

06/09

By Adriano Marchese

Trulieve Cannabis intends to launch a share-repurchase program to buy back up to $50 million over the course of a one-year period.

The medical cannabis company said that its board has authorized the company to repurchase up to around 8.5 million shares for cancellation.

Earlier in the week, Trulieve received regulatory approval to list its shares on the New York Stock Exchange, becoming the first cannabis company cleared to trade on a major U.S. stock exchange. Currently its shares are listed on the Canadian Securities Exchange.

Shares on the CSE have been performing well, with the stock rising over 52% since the start of the year to close Monday at 18.15 Canadian dollars ($13.01).

Trulieve can buy back shares until June 16 of next year.

Write to Adriano Marchese at adriano.marchese@wsj.com

(END) Dow Jones Newswires

June 09, 2026 08:13 ET (12:13 GMT)

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2642467156"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2642467156\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2642467156?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-09 20:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2642467156","market":"sg","top_or_hot":-1,"title":"Trulieve Cannabis Board Approves $50M Buyback Program","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Adriano Marchese \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Trulieve Cannabis intends to launch a share-repurchase program to buy back up to $50 million over the course of a one-year period. \n</p>\n<p>\n  The medical cannabis company said that its board has authorized the company to repurchase up to around 8.5 million shares for cancellation. \n</p>\n<p>\n  Earlier in the week, Trulieve received regulatory approval to list its shares on the New York Stock Exchange, becoming the first cannabis company cleared to trade on a major U.S. stock exchange. Currently its shares are listed on the Canadian Securities Exchange. \n</p>\n<p>\n  Shares on the CSE have been performing well, with the stock rising over 52% since the start of the year to close Monday at 18.15 Canadian dollars ($13.01). \n</p>\n<p>\n  Trulieve can buy back shares until June 16 of next year. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 09, 2026 08:13 ET (12:13 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Trulieve Cannabis Board Approves $50M Buyback Program</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTrulieve Cannabis Board Approves $50M Buyback Program\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2026-06-09 20:13</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Adriano Marchese \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Trulieve Cannabis intends to launch a share-repurchase program to buy back up to $50 million over the course of a one-year period. \n</p>\n<p>\n  The medical cannabis company said that its board has authorized the company to repurchase up to around 8.5 million shares for cancellation. \n</p>\n<p>\n  Earlier in the week, Trulieve received regulatory approval to list its shares on the New York Stock Exchange, becoming the first cannabis company cleared to trade on a major U.S. stock exchange. Currently its shares are listed on the Canadian Securities Exchange. \n</p>\n<p>\n  Shares on the CSE have been performing well, with the stock rising over 52% since the start of the year to close Monday at 18.15 Canadian dollars ($13.01). \n</p>\n<p>\n  Trulieve can buy back shares until June 16 of next year. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 09, 2026 08:13 ET (12:13 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MJ","symbol_name":"Amplify Alternative Harvest ETF","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2642467156","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2642467156","pubTimestamp":1781007180,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Trulieve Cannabis intends to launch a share-repurchase program to buy back up to $50 million over the course of a one-year period.The medical cannabis company said that its board has authorized the company to repurchase up to around 8.5 million shares for cancellation.Earlier in the week, Trulieve received regulatory approval to list its shares on the New York Stock Exchange, becoming the first cannabis company cleared to trade on a major U.S. stock exchange. Currently its shares are listed on the Canadian Securities Exchange.Shares on the CSE have been performing well, with the stock rising over 52% since the start of the year to close Monday at 18.15 Canadian dollars .Trulieve can buy back shares until June 16 of next year.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MJ":"Amplify Alternative Harvest ETF","MSOX":"AdvisorShares MSOX 2X Daily ETF","CNBS":"Amplify Seymour Cannabis ETF","MSOS":"AdvisorShares Pure US Cannabis ETF","YOLO":"AdvisorShares Pure Cannabis ETF","TOKE":"Cambria Cannabis ETF","WEED":"Roundhill Cannabis ETF"},"translate_title":"Trulieve Cannabis董事会批准5000万美元回购计划","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CNBS":1.5,"YOLO":1.5,"TOKE":1.5,"MJ":1.5,"WEED":1.5,"MSOS":1.5,"MSOX":1.5},"content_text":"By Adriano Marchese \n\n\n \n\n\n  Trulieve Cannabis intends to launch a share-repurchase program to buy back up to $50 million over the course of a one-year period. \n\n\n  The medical cannabis company said that its board has authorized the company to repurchase up to around 8.5 million shares for cancellation. \n\n\n  Earlier in the week, Trulieve received regulatory approval to list its shares on the New York Stock Exchange, becoming the first cannabis company cleared to trade on a major U.S. stock exchange. Currently its shares are listed on the Canadian Securities Exchange. \n\n\n  Shares on the CSE have been performing well, with the stock rising over 52% since the start of the year to close Monday at 18.15 Canadian dollars ($13.01). \n\n\n  Trulieve can buy back shares until June 16 of next year. \n\n\n \n\n\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 09, 2026 08:13 ET (12:13 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}